The type III secretion effector NleE inhibits NF-κB activation

Chen Nadler*, Kobi Baruch, Simi Kobi, Erez Mills, Gili Haviv, Marganit Farago, Irit Alkalay, Sina Bartfeld, Thomas F. Meyer, Yinon Ben-Neriah, Ilan Rosenshine

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

145 Scopus citations


The complex host-pathogen interplay involves the recognition of the pathogen by the host's innate immune system and countermeasures taken by the pathogen. Detection of invading bacteria by the host leads to rapid activation of the transcription factor NF-κB, followed by inflammation and eradication of the intruders. In response, some pathogens, including enteropathogenic Escherichia coli (EPEC), acquired means of blocking NF-kB activation. We show that inhibition of NF-κB activation by EPEC involves the injection of NleE into the host cell. Importantly, we show that NleE inhibits NF-κB activation by preventing activation of IKKβ and consequently the degradation of the NF-κB inhibitor, IκB. This NleE activity is enhanced by, but is not dependent on, a second injected effector, NleB. In conclusion, this study describes two effectors, NleB and NleE, with no similarity to other known proteins, used by pathogens to manipulate NF-κB signaling pathways.

Original languageAmerican English
Article numbere1000743
JournalPLoS Pathogens
Issue number1
StatePublished - Jan 2010


Dive into the research topics of 'The type III secretion effector NleE inhibits NF-κB activation'. Together they form a unique fingerprint.

Cite this